Emtricitab/Rilpiviri/Tenof Ala
Brand name: Odefsey
Rank #120 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$144.1M
Total Cost
37,441
Total Claims
$144.1M
Total Cost
1,247
Prescribers
$3,849
Cost per Claim
1,024
Beneficiaries
39,998
30-Day Fills
$116K
Avg Cost/Provider
30
Avg Claims/Provider
Share of Medicare Part D Spending
0.05%
of total Medicare Part D spending
$144.1M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $144.1M total
🔎 Data Overview
At $3,849 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $115,578 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $140,747 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Emtricitab/Rilpiviri/Tenof Ala
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Rosa Diring | Nurse Practitioner | Norfolk, VA | 252 | $948K |
| 2 | Leia Hoang | Pharmacist | San Diego, CA | 101 | $943K |
| 3 | Leonard Berkowitz | Infectious Disease | Brooklyn, NY | 199 | $818K |
| 4 | Mark Higgins | Internal Medicine | San Francisco, CA | 198 | $783K |
| 5 | Jyoti Samant | Infectious Disease | Montgomery, AL | 165 | $736K |
| 6 | Sharon Reiley | Nurse Practitioner | Jacksonville, FL | 199 | $698K |
| 7 | Peter Leahey | Internal Medicine | Portland, OR | 74 | $680K |
| 8 | Peter Alpert | Infectious Disease | Bronx, NY | 173 | $644K |
| 9 | Caitlin Williams | Nurse Practitioner | Thaxton, MS | 153 | $595K |
| 10 | Hillary Hartung | Physician Assistant | Norfolk, VA | 159 | $581K |
| 11 | Robert Kalayjian | Infectious Disease | Cleveland, OH | 159 | $577K |
| 12 | Jason Flamm | Internal Medicine | Sacramento, CA | 59 | $561K |
| 13 | David Aboulafia | Hematology-Oncology | Seattle, WA | 148 | $558K |
| 14 | Ethan Dungan | Nurse Practitioner | Birmingham, AL | 145 | $557K |
| 15 | Rachel Chasan | Infectious Disease | New York, NY | 139 | $512K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 117 | Dolutegravir/Rilpivirine (Juluca) | $148.9M | 41,081 |
| 118 | Lisinopril (Lisinopril) | $145.8M | 15,744,768 |
| 119 | Ofatumumab (Kesimpta Pen) | $144.6M | 14,774 |
| 120 | Emtricitab/Rilpiviri/Tenof Ala (Odefsey) | $144.1M | 37,441 |
| 121 | Eltrombopag Olamine (Promacta) | $142.8M | 10,876 |
| 122 | Alpha-1-Proteinase Inhibitor (Prolastin C) | $137.9M | 12,352 |
| 123 | Dasatinib (Sprycel) | $136.8M | 10,389 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology